Ocugen Analyst Price Targets

SPY—QQQ—BTC/USD—DIA—GLD—TLT—

Premium

Ocugen Inc

OCGNNASDAQ

Trade with Public

$0.7803

-0.0334-4.1%

Last update: Oct 16, 7:58 PM

$0.8025

-0.0112-1.38%

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Ocugen Analyst Price Targets

Wall Street analyst price targets and consensus rating for Ocugen (OCGN).

Price Target Range — 9 Quarters

Analyst Consensus — 5 Analysts

5Buy

Consensus RatingBuy# Analysts5Avg. Consensus PT$8Upside to Avg. PT+934.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 10, 2026	HC Wainwright & Co.	Swayampakula Ramakanth	PT Cut	Buy	$10→$10
May 27, 2026	Canaccord Genuity	Whitney Ijem	PT Cut	Buy	$12→$11
Mar 25, 2026	Chardan Capital	Daniil Gataulin	Maintained	Buy	$7
Mar 25, 2026	HC Wainwright & Co.	Swayampakula Ramakanth	PT Raise	Buy	$7→$10
Mar 17, 2026	Canaccord Genuity	Whitney Ijem	Initiate	Buy	$12
Mar 11, 2026	Oppenheimer	Leland Gershell	Initiate	Outperform	$10
Mar 5, 2026	Chardan Capital	Daniil Gataulin	Maintained	Buy	$7
Jan 20, 2026	Chardan Capital	Daniil Gataulin	Maintained	Buy	$7
Sep 19, 2025	Chardan Capital	Daniil Gataulin	Maintained	Buy	$7
Aug 4, 2025	Chardan Capital	Daniil Gataulin	Maintained	Buy	$7
Jun 24, 2025	Chardan Capital	Daniil Gataulin	Maintained	Buy	$7
Jun 24, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$7
May 12, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	PT Cut	Buy	$8→$7
May 12, 2025	Chardan Capital	Daniil Gataulin	Maintained	Buy	$7
Mar 6, 2025	Chardan Capital	Daniil Gataulin	PT Raise	Buy	$6→$7
Mar 6, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$8
Feb 13, 2025	Chardan Capital	Daniil Gataulin	Maintained	Buy	$6
Feb 13, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	PT Raise	Buy	$7→$8
Jan 23, 2025	Chardan Capital	Daniil Gataulin	Maintained	Buy	$6
Jan 13, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$7

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on Ocugen, Lowers Price Target to $9.5

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Ocugen (NASDAQ:OCGN) with a Buy and lowers the price target from $10 to $9.5.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Buy on Ocugen, Lowers Price Target to $11

Canaccord Genuity analyst Whitney Ijem maintains Ocugen (NASDAQ:OCGN) with a Buy and lowers the price target from $12 to $11.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Ocugen, Raises Price Target to $10

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Ocugen (NASDAQ:OCGN) with a Buy and raises the price target from $7 to $10.

Benzinga Newsdesk

PRO
Canaccord Genuity Initiates Coverage On Ocugen with Buy Rating, Announces Price Target of $12

Canaccord Genuity analyst Whitney Ijem initiates coverage on Ocugen (NASDAQ:OCGN) with a Buy rating and announces Price Target of $12.

Benzinga Newsdesk

This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday

Top Wall Street analysts changed outlook on top names. For all analyst rating changes, see analyst ratings page. Analysts' thoughts on LGND stock.

Avi Kapoor

PRO
Oppenheimer Initiates Coverage On Ocugen with Outperform Rating, Announces Price Target of $10

Oppenheimer analyst Leland Gershell initiates coverage on Ocugen (NASDAQ:OCGN) with a Outperform rating and announces Price Target of $10.

Benzinga Newsdesk

Ocugen Inc

Ocugen Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on Ocugen, Lowers Price Target to $9.5

PRO
Canaccord Genuity Maintains Buy on Ocugen, Lowers Price Target to $11

PRO
HC Wainwright & Co. Maintains Buy on Ocugen, Raises Price Target to $10

PRO
Canaccord Genuity Initiates Coverage On Ocugen with Buy Rating, Announces Price Target of $12

This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday

PRO
Oppenheimer Initiates Coverage On Ocugen with Outperform Rating, Announces Price Target of $10

Ocugen Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on Ocugen, Lowers Price Target to $9.5

PRO
Canaccord Genuity Maintains Buy on Ocugen, Lowers Price Target to $11

PRO
HC Wainwright & Co. Maintains Buy on Ocugen, Raises Price Target to $10

PRO
Canaccord Genuity Initiates Coverage On Ocugen with Buy Rating, Announces Price Target of $12

This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday

PRO
Oppenheimer Initiates Coverage On Ocugen with Outperform Rating, Announces Price Target of $10

People Also Watch

People Also Watch

Ocugen Inc

Ocugen Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROHC Wainwright & Co. Maintains Buy on Ocugen, Lowers Price Target to $9.5

PROCanaccord Genuity Maintains Buy on Ocugen, Lowers Price Target to $11

PROHC Wainwright & Co. Maintains Buy on Ocugen, Raises Price Target to $10

PROCanaccord Genuity Initiates Coverage On Ocugen with Buy Rating, Announces Price Target of $12

This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday

PROOppenheimer Initiates Coverage On Ocugen with Outperform Rating, Announces Price Target of $10

Ocugen Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROHC Wainwright & Co. Maintains Buy on Ocugen, Lowers Price Target to $9.5

PROCanaccord Genuity Maintains Buy on Ocugen, Lowers Price Target to $11

PROHC Wainwright & Co. Maintains Buy on Ocugen, Raises Price Target to $10

PROCanaccord Genuity Initiates Coverage On Ocugen with Buy Rating, Announces Price Target of $12

This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday

PROOppenheimer Initiates Coverage On Ocugen with Outperform Rating, Announces Price Target of $10

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Maintains Buy on Ocugen, Lowers Price Target to $9.5

PRO
Canaccord Genuity Maintains Buy on Ocugen, Lowers Price Target to $11

PRO
HC Wainwright & Co. Maintains Buy on Ocugen, Raises Price Target to $10

PRO
Canaccord Genuity Initiates Coverage On Ocugen with Buy Rating, Announces Price Target of $12

PRO
Oppenheimer Initiates Coverage On Ocugen with Outperform Rating, Announces Price Target of $10

PRO
HC Wainwright & Co. Maintains Buy on Ocugen, Lowers Price Target to $9.5

PRO
Canaccord Genuity Maintains Buy on Ocugen, Lowers Price Target to $11

PRO
HC Wainwright & Co. Maintains Buy on Ocugen, Raises Price Target to $10

PRO
Canaccord Genuity Initiates Coverage On Ocugen with Buy Rating, Announces Price Target of $12

PRO
Oppenheimer Initiates Coverage On Ocugen with Outperform Rating, Announces Price Target of $10